Nathaniel S. Gardiner
2017
In 2017, Nathaniel S. Gardiner earned a total compensation of $1.5M as Senior Vice President and General Counsel at Enanta Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $151,200 |
---|---|
Option Awards | $428,275 |
Salary | $368,100 |
Stock Awards | $545,550 |
Other | $18,551 |
Total | $1,511,676 |
Gardiner received $545.6K in stock awards, accounting for 36% of the total pay in 2017.
Gardiner also received $151.2K in non-equity incentive plan, $428.3K in option awards, $368.1K in salary and $18.6K in other compensation.
Rankings
In 2017, Nathaniel S. Gardiner's compensation ranked 6,949th out of 14,666 executives tracked by ExecPay. In other words, Gardiner earned more than 52.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,949 | 53rd |
Manufacturing | 2,575 | 55th |
Chemicals And Allied Products | 833 | 60th |
Drugs | 647 | 63rd |
Pharmaceutical Preparations | 508 | 62nd |
Gardiner's colleagues
We found four more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2017.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019